Key players in Overactive Bladder Treatment
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | Astellas Pharma Inc. | — | 264 reports |
| 2 | Urovant (Sumitomo Pharma) | — | 33 reports |
| 3 |  AbbVie Inc. |
abbvie.com (opens in a new tab) | 1,254 reports |
| 4 |  Medtronic |
medtronic.com (opens in a new tab) | 2,343 reports |
| 5 | Axonics (Boston Scientific) | — | 33 reports |
Also active in Overactive Bladder Treatment
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
| Macleods Pharmaceuticals | |
| InnoCon Medical |
|
| Zydus Lifesciences | |
| Stimuli Technology |
|
| Unichem Laboratories Ltd | |
| Alembic Therapeutics | |
 Aurobindo Pharma |
|
| Alkem Laboratories Ltd | |
| Unique | |
| Padagis US | |
| Ajanta Pharma Ltd | |
| Torrent |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Overactive Bladder Treatment
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- Axonics (Boston Scientific) 3 active trials on ClinicalTrials.gov (opens in a new tab)
- InnoCon Medical 3 active trials on ClinicalTrials.gov (opens in a new tab)
- Stimuli Technology 2 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Overactive Bladder Treatment reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Overactive Bladder Treatment report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.